[1] 邓华亚,徐新,张社兵. 深静脉血栓形成诊断研究进展[J]. 中国心血管病研究,2016,14: 678-681. [2] Sáez-Giménez B, Berastegui C, Loor K, et al.Deep vein thrombosis and pulmonary embolism after solid organ transplantation: an unresolved problem[J]. Transplant Rev (Orlando),2015,29: 85-92. [3] Hong J,Lee JH,Yhim HY,et al.Incidence of venous thromboembolism in Korea from 2009 to 2013[J]. PLoS One,2018,13: e0191897.doi: 10.1371/journal.pone.0191897. [4] 张玥,侯玉芬,刘明.炎性细胞因子在深静脉血栓形成中的作用[J]. 中国中西医结合外科杂志,2006,12: 590-592. [5] 蒋知云,马俊芬,明亮.microRNA 在深静脉血栓形成中的作用及临床价值研究进展[J]. 医学研究生学报,2017,30: 893-896. [6] Jeraj L,Spirkoska A,Jezovnik MK,et al. Deep vein thrombosis and properties of the arterial wall[J]. Vasa,2018,47: 197-201. [7] Heit JA,Spencer FA,White RH.The epidemiology of venous thromboembolism[J]. J Thromb Thrombolysis,2016,41: 3-14. [8] Gurha P. MicroRNAs in cardiovascular disease[J]. Curr Opin Cardiol,2016,31: 249-254. [9] Daniel JM, Penzkofer D, Teske R, et al. Inhibition of miR-92a improves re-endothelialization and prevents neom-tima formation following vascular injury[J]. Cardiovasc Res, 2014, 103:564-572. [10] Kong L, Hu N, Du X, et al. Upregulation of miR-483-3p contributes to endothelial progenitor cells dysfunction in deep vein thrombosis patients via SRF[J]. J Transl Med, 2016, 14:23. doi: 10.1186/s12967-016-0775-2. [11] Kong L, Du X, Hu N, et al. Downregulation of let-7e-5p contributes to endothelial progenitor cell dysfunction in deep thrombosis via targeting FASLG[J]. Thromb Res, 2016,138:30-36. [12] Bijak M, Dziedzic A, Synowiec E, et al. Flavonolignans inhibit IL1-β-induced cross-talk between blood platelets and leukocytes[J]. Nutrients, 2017, 9:1022. doi: 10.3390/nu9091022. |